Latest announcements on new methods, partnerships, regulatory milestones, and company updates from Masdiag Diagnostic Laboratory.
Masdiag contributes to Mongolia's first nationwide newborn screening programme in partnership with UNICEF Mongolia and Esun Med LLC.
January 2026 Product LaunchNew LC-MS/MS method for LPC-VLCFA analysis from dried blood spot enables faster and more accessible X-ALD and peroxisomal disorder screening.
October 2025 Research GrantMasdiag's innovative diagnostic project for dementia risk assessment has been selected by PARP for promotional support under the SMART Path programme.
September 2025 PublicationResearch co-developed by Masdiag's team on Mycobacterium species identification by flow injection analysis-mass spectrometry published in Nature Scientific Reports.
May 2025 PartnershipNew partnership to develop and implement a DBS-based 3-O-methyldopa screening tool for AADC deficiency detection across Europe.
March 2025 ResearchMasdiag joins an international consortium investigating lifestyle-based interventions for brain health and cognitive decline prevention.
March 2025 EU FundingMasdiag receives PLN 3,028,154 in European Funds under the Smart Economy Programme for an innovative DBS-based dementia risk test.
March 2025 AdvocacyKonrad Kowalski presents Masdiag's work on rare disease diagnostics and congenital defects of metabolism to Poland's Parliamentary Group at the Sejm.
February 2025 InnovationEP3922990 granted for an automatic column switching system with disposable chromatographic columns, designed to optimise LC/MS diagnostics.
May 2024